Search

everythinglearnresearchcommunity

for

Search:↓

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Pantethine may boost the immune system's ability to fight sarcoma.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

3D cell-derived matrices improve tissue regeneration and disease modeling.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

GFP transgenic mice help study cell origins in skin grafts.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Sub3 is essential for fungus adherence but not for skin invasion.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

PRP can help treat hair loss but needs standardized methods for best results.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

PRGF is a promising treatment for hair loss with some patient benefits.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Low-molecular weight hyaluronate can make damaged hair stronger.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

The review concluded that better studies are needed to prove if Low-Level Laser Therapy devices for hair growth really work.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Low Level Laser Therapy can promote hair growth.

Low-dose UVB light improves hair growth effects of certain stem cells by increasing reactive oxygen species.